Predicting Pathologic Stage, Nomograms, and Clinical Judgment: Don't Miss the Forest for the Trees!

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 2, 2009, Pages 325-326

  Roach III, Mack ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; EDITORIAL; GLEASON SCORE; LYMPH NODE; NOMOGRAM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE;

ALGORITHMS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; NOMOGRAMS; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 58149330216     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.05.056     Document Type: Editorial

References (10)

1. Roach M. Equations for predicting the pathologic stage of men with localized prostate cancer using the preoperative prostate specific antigen (PSA) and Gleason score. J Urol 150 (1993) 1923-1924
2. Seaward S.A., Weinberg V., Lewis P., et al. Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 1055-1062
3. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
4. Nguyen P.L., and D'Amico A.V. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials. J Clin Oncol 26 (2008) 2055-2056 author reply 2056-2057
5. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
6. Briganti A., Chun F.K., Salonia A., et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology 69 (2007) 147-151
7. Pagliarulo V., Hawes D., Brands F.H., et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 24 (2006) 2735-2742
8. Ferrari A.C., Stone N.N., Kurek R., et al. Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment. J Clin Oncol 24 (2006) 3081-3088
9. Shariat S.F., Kattan M.W., Erdamar S., et al. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. J Clin Oncol 21 (2003) 1223-1231
10. Miyake H., Hara I., Kurahashi T., et al. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. Clin Cancer Res 13 (2007) 1192-1197